Followers | 604 |
Posts | 24107 |
Boards Moderated | 3 |
Alias Born | 12/06/2009 |
Thursday, August 24, 2017 2:00:48 AM
The purpose of the project MACIVIVA is to develop Vaccine based tablets that are not required to be put in cold storage so that they can have longer storage life and be transferred and delivered around the world efficiently.
freeze dried zydis tablets are designed to store a manufactured vaccine which dissolves on the human tongue within 3 seconds.
Mymetics is the partner that is required in Maciviva to produce the virosome membranes. They have developed the virosome to be completely able to be packaged into freeze dried soluble tablets.
Catalent (NYSE) is another partner on the Maciviva project... they are responsible for the tablets..
but none of which is possible without Mymetics virosome membranes.. These membranes are able to "DELIVER" the vaccine to the human effectively.
http://www.catalent.com/index.php/news-events/news/Catalent-Awarded-Grant-As-Part-Of-Vaccine-Research-Consortium
"No More Pricks"
http://www.maciviva.eu
The MACIVIVA project ends in November.
This will change human history. forever. I expect Sanofi to buy out Mymetics for anywhere in the range of 600 million to 2.5 billion dollars.. this is an estimate of lower end numbers in my opinion.
just my opinion.
MYMX could be bought out for anywhere from 1-5 dollars per share imo.
Sanofi will make a move on it this year imo.
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM